We explain how ACA health insurance marketplaces work, why enrollment has grown recently, what’s at the heart of the US government shutdown and what’s at stake for consumers.
Expert Commentary
Though little known to the public, the USPSTF plays a key role in determining which preventive care services health insurers must cover without out-of-pocket costs.
Expert Commentary
Read on to learn how pharmacy benefit managers influence drug prices in the U.S., and how academic studies can help you gain a deeper understanding of the concerns about PBMs. PLUS: 4 tips for localizing and covering stories about PBMs.
Expert Commentary
For any journalist who covers health care in the U.S., it’s important to understand and continue to consider the potential consequences of striking down the 40-year-old legal doctrine.
Expert Commentary
The largest health insurer in the United States does not cover weight-loss drugs. This piece explains the issue and summarizes some recent publications on the benefits and costs of drugs like semaglutide and tirzepatide.
Expert Commentary
To help journalists report on Medicaid, we’ve summarized a few studies that can inform reporters about key debates happening about this program.
Expert Commentary
The medical system is responsible for a surprisingly large percentage of greenhouse gas emissions, and the toll is especially heavy in the U.S. We look at how governments are responding and what research reveals — and offer some timely story ideas for journalists.
Expert Commentary
Private equity firms argue they bring value to health care. Critics of private equity’s approach say the intense drive for quick profit puts patients at risk. We look at the research.
Expert Commentary
Health insurance companies argue that prior authorization can reduce unnecessary procedures and health care costs. But doctors have concerns about the frequency of these requests, even for routine procedures, and the administrative burdens associated with them.
Expert Commentary
Accelerated approval is an important topic for journalists to consider in their ongoing coverage of drug costs in America. This article explains how the process works — including examples of successes and controversies. Plus: 5 reporting tips.
Expert Commentary